Children's Hospital Los Angeles received $2.8 million from the National Institutes of Health to use an artificial intelligence-based tool to help predict the optimal medication dosage that children in the ICU will need over time.
Michael Neely's, MD, chief of the division of infectious diseases at Children's Hospital Los Angeles, lab will use special statistical algorithms — a set of rules used in problem-solving operations — to describe clinical measurements of critically ill children over time that may fluctuate independently of each other.
The researchers will then test these algorithms to measure patient exposure to medication over time, according to a Dec. 19 release from Children's Hospital Los Angeles.
The aim is to create a tool that will help physicians determine the safe and effective amounts of medication needed to dose unstable ICU patients.